Innovative and evolutive, the health sector is seeing significant regulatory and operational transformations, particularly with the development of “connected health” and telehealth. Our dedicated multidisciplinary team assists its clients in the entirety of issues specific to their sector.
Our team dedicated to public health has developed specific savoir-faire and advises figures from this market throughout their projects: ensuring that the strategy is consistent with legal and regulatory frameworks, advising founders on choosing a suitable legal structure, assistance in the social management of strategic reorganisation, acquisition or transmission of essential intellectual property for these kinds of projects, protection of enterprise-specific knowledge, marketing of products and, if required, assistance with litigations.
Recognised for its expertise and knowledge of the sector, our team assists clients involved in the domains of medicines, medical devices, biotechnologies, services to aid medical diagnoses, as well as so-called “borderline” products. Our team also advises public and private healthcare facilities and groups (French Public Interest Groups [GIP], French Healthcare Cooperation Groups [GCS]).
The team members are also involved in the development of “connected health”, assisting different business incubators active within this sector, including various young “medtech” companies.
Our team works in coordination with its national and international networks, notably through the establishment of Bignon Lebray in China, in order to assist its clients.
Some references
- Our team has advised several industrial groups within the human health and veterinary sectors regarding the organisation of health product distribution and marketing;
- Our experts have advised a wholesaler-distributor on personal-data issues;
- We have assisted a group of chemists and veterinarians in implementing contractual relationships with their adherents and reference partners;
- Our firm has assisted several “medtechs” regarding personal data and the licensing of intellectual property.
